Govt expert panel accepts Covaxin phase-3 trial data
New Delhi: An expert panel of the country’s central drugs authority has reviewed and accepted the phase-3 trial data of Bharat Biotech’s COVID-19 vaccine Covaxin, sources said on Tuesday.According to the data submitted by the…